Gillies Hunter
SEC CIK 1868997 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| JBIO | Jade Biosciences, Inc. | Chief MEDICAL Off | 5,602 | — | $1.56M | 30 | 2023-04-21 | 2024-06-13 |
Most active insiders at JBIO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Balta Elizabeth | See Remarks | — | — |
| 2 | Frohlich Tom | CEO, Dir | — | — |
| 3 | King Andrew James | See Remarks | — | — |
| 4 | Dahms Bradford D. | CFO | — | — |
| 5 | Fairmount Healthcare Fund II L.P. | Dir, 10% | — | — |
Gillies Hunter made no open-market trades at JBIO in the last 12 months.
Transactions 30
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-14 | 2024-06-13 | JBIO | Jade Biosciences, Inc. | Gillies Hunter | Chief MEDICAL Off | S - Sale+OE | $24.50 | -6,000 | 5,602 | -52% | -$147.0K |
| D | 2024-06-14 | 2024-06-13 | JBIO | Jade Biosciences, Inc. | Gillies Hunter | Chief MEDICAL Off | M - OptEx | $2.14 | +6,000 | 11.6K | +107% | +$12.8K |
| DM | 2024-05-17 | 2024-05-17 | JBIO | Jade Biosciences, Inc. | Gillies Hunter | Chief MEDICAL Off | S - Sale+OE | $21.09 | -4,000 | 5,688 | -41% | -$84.3K |
| D | 2024-05-17 | 2024-05-17 | JBIO | Jade Biosciences, Inc. | Gillies Hunter | Chief MEDICAL Off | M - OptEx | $2.14 | +4,000 | 9,602 | +71% | +$8,560 |
| DM | 2024-04-19 | 2024-04-17 | JBIO | Jade Biosciences, Inc. | Gillies Hunter | Chief MEDICAL Off | S - Sale+OE | $22.38 | -4,000 | 3,562 | -53% | -$89.5K |
| D | 2024-04-19 | 2024-04-17 | JBIO | Jade Biosciences, Inc. | Gillies Hunter | Chief MEDICAL Off | M - OptEx | $1.74 | +4,000 | 7,251 | +123% | +$6,960 |
| D | 2024-04-01 | 2024-03-28 | JBIO | Jade Biosciences, Inc. | Gillies Hunter | Chief MEDICAL Off | S - Sale+OE | $29.50 | -9,000 | 3,251 | -73% | -$265.5K |
| D | 2024-04-01 | 2024-03-28 | JBIO | Jade Biosciences, Inc. | Gillies Hunter | Chief MEDICAL Off | M - OptEx | $2.14 | +9,000 | 12.3K | +277% | +$19.3K |
| DM | 2024-03-20 | 2024-03-18 | JBIO | Jade Biosciences, Inc. | Gillies Hunter | Chief MEDICAL Off | S - Sale+OE | $25.86 | -7,000 | 3,251 | -68% | -$181.0K |
| DM | 2024-03-20 | 2024-03-18 | JBIO | Jade Biosciences, Inc. | Gillies Hunter | Chief MEDICAL Off | M - OptEx | $1.91 | +7,000 | 7,251 | +2,789% | +$13.4K |
| D | 2024-03-11 | 2024-03-07 | JBIO | Jade Biosciences, Inc. | Gillies Hunter | Chief MEDICAL Off | S - Sale+OE | $24.50 | -8,975 | 3,251 | -73% | -$219.9K |
| D | 2024-03-11 | 2024-03-07 | JBIO | Jade Biosciences, Inc. | Gillies Hunter | Chief MEDICAL Off | M - OptEx | $2.14 | +8,975 | 12.2K | +276% | +$19.2K |
| D | 2024-02-27 | 2024-02-23 | JBIO | Jade Biosciences, Inc. | Gillies Hunter | Chief MEDICAL Off | M - OptEx | $1.74 | +511 | 3,762 | +16% | +$889.14 |
| D | 2024-02-27 | 2024-02-23 | JBIO | Jade Biosciences, Inc. | Gillies Hunter | Chief MEDICAL Off | S - Sale+OE | $19.50 | -511 | 3,251 | -14% | -$9,964 |
| DM | 2024-02-22 | 2024-02-20 | JBIO | Jade Biosciences, Inc. | Gillies Hunter | Chief MEDICAL Off | S - Sale+OE | $20.23 | -3,489 | 3,251 | -52% | -$70.6K |
| D | 2024-02-22 | 2024-02-20 | JBIO | Jade Biosciences, Inc. | Gillies Hunter | Chief MEDICAL Off | M - OptEx | $1.74 | +3,489 | 6,740 | +107% | +$6,071 |
| D | 2024-01-19 | 2024-01-17 | JBIO | Jade Biosciences, Inc. | Gillies Hunter | Chief MEDICAL Off | M - OptEx | $1.74 | +4,000 | 7,251 | +123% | +$6,960 |
| D | 2024-01-19 | 2024-01-17 | JBIO | Jade Biosciences, Inc. | Gillies Hunter | Chief MEDICAL Off | S - Sale+OE | $19.50 | -4,000 | 3,251 | -55% | -$78.0K |
| D | 2023-12-29 | 2023-12-27 | JBIO | Jade Biosciences, Inc. | Gillies Hunter | Chief MEDICAL Off | S - Sale+OE | $24.50 | -125 | 3,251 | -4% | -$3,062 |
| D | 2023-12-29 | 2023-12-27 | JBIO | Jade Biosciences, Inc. | Gillies Hunter | Chief MEDICAL Off | M - OptEx | $2.14 | +125 | 3,376 | +4% | +$267.50 |
| D | 2023-12-22 | 2023-12-13 | JBIO | Jade Biosciences, Inc. | Gillies Hunter | Chief MEDICAL Off | M - OptEx | $1.74 | +4,000 | 7,251 | +123% | +$6,960 |
| D | 2023-12-22 | 2023-12-20 | JBIO | Jade Biosciences, Inc. | Gillies Hunter | Chief MEDICAL Off | S - Sale+OE | $19.50 | -4,000 | 3,251 | -55% | -$78.0K |
| DM | 2023-12-15 | 2023-12-13+ | JBIO | Jade Biosciences, Inc. | Gillies Hunter | Chief MEDICAL Off | M - OptEx | $1.74 | +12.0K | 5,354 | New | +$20.9K |
| DM | 2023-12-15 | 2023-12-13+ | JBIO | Jade Biosciences, Inc. | Gillies Hunter | Chief MEDICAL Off | S - Sale+OE | $19.50 | -12.0K | 3,251 | -79% | -$234.0K |
| D | 2023-05-23 | 2023-05-19 | JBIO | Jade Biosciences, Inc. | Gillies Hunter | Chief MEDICAL Off | M - OptEx | $1.74 | +65 | 3,316 | +2% | +$113.10 |
| D | 2023-05-23 | 2023-05-19 | JBIO | Jade Biosciences, Inc. | Gillies Hunter | Chief MEDICAL Off | S - Sale+OE | $19.50 | -65 | 3,251 | -2% | -$1,268 |
| D | 2023-05-19 | 2023-05-17 | JBIO | Jade Biosciences, Inc. | Gillies Hunter | Chief MEDICAL Off | S - Sale+OE | $19.59 | -1,090 | 3,251 | -25% | -$21.4K |
| D | 2023-05-19 | 2023-05-17 | JBIO | Jade Biosciences, Inc. | Gillies Hunter | Chief MEDICAL Off | M - OptEx | $1.74 | +1,090 | 4,341 | +34% | +$1,897 |
| D | 2023-04-25 | 2023-04-21 | JBIO | Jade Biosciences, Inc. | Gillies Hunter | Chief MEDICAL Off | S - Sale+OE | $19.50 | -4,000 | 1,960 | -67% | -$78.0K |
| D | 2023-04-25 | 2023-04-21 | JBIO | Jade Biosciences, Inc. | Gillies Hunter | Chief MEDICAL Off | M - OptEx | $1.74 | +4,000 | 5,960 | +204% | +$6,960 |
Purchase Sale Sale after option exercise All abbreviations